Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
University of Kansas Medical Center
University of Kansas Medical Center
M.D. Anderson Cancer Center
BGI, China
Karolinska University Hospital
Mie University
Ruijin Hospital
Shenzhen Second People's Hospital
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)